Cargando…
Respiratory and systemic monocytes, dendritic cells, and myeloid‐derived suppressor cells in COVID‐19: Implications for disease severity
Since the beginning of the SARS‐CoV‐2 pandemic in 2020, researchers worldwide have made efforts to understand the mechanisms behind the varying range of COVID‐19 disease severity. Since the respiratory tract is the site of infection, and immune cells differ depending on their anatomical location, st...
Autores principales: | Falck‐Jones, Sara, Österberg, Björn, Smed‐Sörensen, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538918/ https://www.ncbi.nlm.nih.gov/pubmed/35996885 http://dx.doi.org/10.1111/joim.13559 |
Ejemplares similares
-
Human influenza virus infection elicits distinct patterns of monocyte and dendritic cell mobilization in blood and the nasopharynx
por: Vangeti, Sindhu, et al.
Publicado: (2023) -
Blood Dendritic Cells, Monocytes and Myeloid-derived Suppressor Cells in Patients with COVID-19 Associated Pneumonia
por: Hancharou, Andrei, et al.
Publicado: (2021) -
Monocytic Myeloid-Derived Suppressor Cells in Chronic Infections
por: Dorhoi, Anca, et al.
Publicado: (2018) -
Monocytic Myeloid Derived Suppressor Cells in Hematological Malignancies
por: Palumbo, Giuseppe Alberto, et al.
Publicado: (2019) -
2783. Expansion of Monocytic Myeloid-Derived Suppressor Cells in Infants with Severe Respiratory Syncytial Virus (RSV) Infection
por: Bedoya, Santiago Acero, et al.
Publicado: (2019)